Skip to main content
. 2021 Sep 7;18(9):e1003766. doi: 10.1371/journal.pmed.1003766

Fig 6. Change in heart rate after antimalarial treatment for uncomplicated malaria in children (age <12 years).

Fig 6

Change in heart rate after treatment with the antimalarials artesunate-amodiaquine (ASAQ), dihydroartemisinin-piperaquine (DP), artemether-lumefantrine (AL), and pyronaridine-artesunate (PyAS) in children aged <12 years from a multivariable linear mixed effects regression model adjusting for age, body temperature, and individual study/site/person effects. Lines indicate means with colour representing antimalarial treatment arm, shaded areas denote 95% confidence intervals, and dots are partial residuals.